These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2562579)
1. [The effect of Listeria factor Ei, BCG vaccine and a combination of both on the growth of experimental syngeneic tumors in inbred mice]. Zák M; Mára M; Jirkovský J Sb Lek; 1989 Sep; 91(8-9):230-7. PubMed ID: 2562579 [TBL] [Abstract][Full Text] [Related]
2. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both]. Zák M; Mára M; Jirkovský J Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG. Yamazaki M; Saito M; Abe S; Mizuno D Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475 [TBL] [Abstract][Full Text] [Related]
4. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]. Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202 [TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of the malignancy of tumors in mice induced by 20-methylcholanthrene]. Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA Eksp Onkol; 1985; 7(5):21-4. PubMed ID: 4065015 [TBL] [Abstract][Full Text] [Related]
6. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of immunostimulating and immunotherapeutic effect of BCG vaccines using listerial endotoxin-like substances. Mára M; Průchová J; Smerák P; John C; Miková Z; Nedvĕdová V; Sir Z Dev Biol Stand; 1986; 58 ( Pt A)():379-87. PubMed ID: 3596044 [TBL] [Abstract][Full Text] [Related]
8. [Effect of sensitization and delayed hypersensitivity reaction on tumor growth in mice]. Polushkin BV; Gordienko SM Vopr Onkol; 1980; 26(7):51-6. PubMed ID: 7405105 [TBL] [Abstract][Full Text] [Related]
9. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy. Vaage J Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431 [TBL] [Abstract][Full Text] [Related]
10. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy. Simmons RL; Rios A Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327 [No Abstract] [Full Text] [Related]
11. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy. Adler A; Altbaum I J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer. Yu DS; Lee CF; Hsieh DS; Chang SY Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment. Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388 [TBL] [Abstract][Full Text] [Related]
14. Proposals for quality control methods of bacterial vaccines for immunostimulation. III. Effect of BCG and C. parvum on in vivo Listeria clearance and tumor growth. Ruitenberg EJ; Steerenberg PA; van Noorle Jansen LM Dev Biol Stand; 1977 Apr 13-15; 38():97-101. PubMed ID: 415924 [TBL] [Abstract][Full Text] [Related]
15. [Effect of the combined use of BCG, PPD, a protein-containing preparation from allogenic tissue and cyclophosphamide in the development of methylcholanthrene-induced tumors]. Volegov AI Eksp Onkol; 1984; 6(2):63-5. PubMed ID: 6510338 [TBL] [Abstract][Full Text] [Related]
16. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens. Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979 [TBL] [Abstract][Full Text] [Related]
17. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells. Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533 [No Abstract] [Full Text] [Related]
18. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070 [TBL] [Abstract][Full Text] [Related]
19. [Effect of repeated administration of BCG vaccine combined with surgery on the growth dynamics of transplantable Guérin tumor in rats]. Nowak HF; Jodczyk KJ; Cylwik B; Zimnoch L; Głowińska L; Duda D; Plezia E; Bernaczyk A Patol Pol; 1981; 32(2):161-71. PubMed ID: 7322638 [No Abstract] [Full Text] [Related]
20. Influence of BCG vaccination on the primary and transplantable hamster tumors induced by SV40 and on the specific SV40 virus-induced antitumor immunity. Zhalgasbayeva GT Neoplasma; 1976; 23(2):129-36. PubMed ID: 180441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]